Apixaban and Hysterectomy - a phase IV clinical study of FDA data

Summary:

Hysterectomy is reported as a side effect among people who take Apixaban (apixaban), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Rinvoq, and have Deep venous thrombosis.

The phase IV clinical study analyzes which people have Hysterectomy when taking Apixaban. It is created by eHealthMe based on reports of 60,044 people who have side effects when taking Apixaban from the FDA, and is updated regularly.

What is Apixaban?

Apixaban has active ingredients of apixaban. It is often used in blood clots. eHealthMe is studying from 60,351 Apixaban users. Check the latest studies of Apixaban.

What is Hysterectomy?

Hysterectomy is found to be associated with 723 drugs and 1,374 conditions by eHealthMe. Check the latest studies of Hysterectomy.

On Jul, 16, 2026

60,044 people reported to have side effects when taking Apixaban.
Among them, 12 people (0.02%) have Hysterectomy.

Among these 12 people:

How long have people been on Apixaban when they have Hysterectomy? *

What is the gender of people who have Hysterectomy when taking Apixaban? *

female: 100 %
male: 0.0 %

What is the age of people who have Hysterectomy when taking Apixaban? *

What are other drugs people take besides Apixaban? *

Rinvoq: 7 people, 58.33%
Metformin Hydrochloride: 5 people, 41.67%
Telmisartan: 5 people, 41.67%
Sulfasalazine: 5 people, 41.67%
Simponi: 5 people, 41.67%
Empagliflozin: 5 people, 41.67%
Magnesium Citrate: 4 people, 33.33%
Methotrexate Sodium: 3 people, 25.00%
Bupropion Hydrochloride: 3 people, 25.00%
Actemra: 3 people, 25.00%

What are other side effects people have besides Hysterectomy? *

Umbilical Hernia (an outward bulging (protrusion) of the abdominal lining or part of the abdominal organ(s) through the area around the belly button): 5 people, 41.67%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 5 people, 41.67%
Diabetes: 5 people, 41.67%
Drug Ineffective: 5 people, 41.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 41.67%
Trigger Finger: 5 people, 41.67%
High Blood Pressure: 5 people, 41.67%
Prostatic Specific Antigen Abnormal: 5 people, 41.67%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 5 people, 41.67%
Pulmonary Toxicity (side effects on the lungs): 5 people, 41.67%

What are the existing conditions these people have? *

Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 3 people, 25.00%
Pulmonary Embolism (blockage of the main artery of the lung): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Apixaban and have Hysterectomy?

- Check whether Hysterectomy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Apixaban:

Apixaban (60,351 reports)

Hysterectomy treatments and more:

Hysterectomy (13,002 reports)

Browse all side effects of Apixaban:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hysterectomy:

Hysterectomy (723 drugs)

Browse all the conditions that are associated with Hysterectomy:

Hysterectomy (1,374 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on apixaban (the active ingredients of Apixaban) and Apixaban (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.